Development of a novel VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies

被引：0

作者：

Seydoux, E. ^{[1
]}

Wan, Y. -H. ^{[1
]}

Feng, J. ^{[1
]}

Wall, A. ^{[1
]}

Aljedani, S. ^{[1
]}

Homad, L. J. ^{[1
]}

MacCamy, A. J. ^{[1
]}

Weidle, C. ^{[1
]}

Gray, M. D. ^{[1
]}

Brumage, L. ^{[1
]}

Taylor, J. J. ^{[1
,2
,3
]}

Pancera, M. ^{[1
]}

Stamatatos, L. ^{[1
,2
]}

McGuire, A. T. ^{[1
,2
]}

机构：

[1] Fred Hutch, VIDD, Seattle, WA USA

[2] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA

[3] Univ Washington, Dept Immunol, Seattle, WA 98195 USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2021年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

OA08.05LB

引用

页数：1

共 15 条

[11] Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor
Kong, Leopold
Ju, Bin
Chen, Yajing
He, Linling
Ren, Li
Liu, Jiandong
Hong, Kunxue
Su, Bin
Wang, Zheng
Ozorowski, Gabriel
Ji, Xiaolin
Hua, Yuanzi
Chen, Yanli
Deller, Marc C.
Hao, Yanling
Feng, Yi
Garces, Fernando
Wilson, Richard
Dai, Kaifan
O'Dell, Sijy
McKee, Krisha
Mascola, John R.
Ward, Andrew B.
Wyatt, Richard T.
Li, Yuxing
Wilson, Ian A.
Zhu, Jiang
Shao, Yiming
IMMUNITY, 2016, 44 (04) : 939 - 950
[12] HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies (vol 14, e1007431, 2018)
LaBranche, Celia C.
McGuire, Andrew T.
Gray, Matthew D.
Behrens, Shay
Chen, Xuejun
Zhou, Tongqing
Sattentau, Quentin J.
Peacock, James
Eaton, Amanda
Greene, Kelli
Gao, Hongmei
Tang, Haili
Perez, Lautaro G.
Saunders, Kevin O.
Kwong, Peter D.
Mascola, John R.
Haynes, Barton F.
Stamatatos, Leonidas
Montefiori, David C.
PLOS PATHOGENS, 2019, 15 (03)
[13] Inadequate anti-idiotypic response, as assessed by antibodies to La/SSB complementary epitopes: A novel component in the development of neonatal lupus
Stea, E. A.
Routsias, J. G.
Clancy, R. M.
Buyon, J. P.
Moutsopoulos, H. M.
Tzioufas, A. G.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A18 - A18
[14] Novel mechanism of action of intravenous immunoglobulin (IVIg): Anti-HLA class I antibodies in IVIg neutralize HLA class I-like anti-idiotypic antibodies (anti-ids) in the sera of highly sensitized (HS) patients
Cardella, Carl J.
Hack, Nashrudeen
Angra, Sarita
McKnight, Theresa
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 574 - 574
[15] Development of Novel Human Anti-HLA-Monoclonal Antibodies for Clinical Applications Using Peripheral Blood B Cells Derived from Anti-HLA Antibody-Positive Donors
Takamatsu, Hiroyuki
Zaimoku, Yoshitaka
Ozawa, Tatsuhiko
Kawai, Shintaro
Tanaka, Hidenori
Kishi, Hiroyuki
Muraguchi, Atsushi
Nakao, Shinji
BLOOD, 2016, 128 (22)

← 1 2 →